May 30, 2018
Gilead Sciences to Present at the Goldman Sachs 39th Annual Global Healthcare Conference on Wednesday, June 13
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 30, 2018--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L.
Washington, Gilead’s Executive Vice President and Chief Financial
Officer, and John McHutchison, Gilead’s Chief Scientific Officer and
Head of Research & Development, will participate in a fireside chat at
the Goldman Sachs 39th Annual Global Healthcare Conference in
Rancho Palos Verdes, CA on Wednesday, June 13 at 8:40 a.m. Pacific Time.
The audio portion of the fireside chat will be accessible live through
the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be required to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead Sciences, Inc.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that
discovers, develops and commercializes innovative medicines in areas of
unmet medical need. The company strives to transform and simplify care
for people with life-threatening illnesses around the world. Gilead has
operations in more than 35 countries worldwide, with headquarters in
Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180530006043/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Investor Relations
